Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective
Retrospective cohort study investigates prognosis following surgery versus maintenance therapy in stage III NSCLC, suggesting defined surgical pathways.
Key Points
Surgical intervention after favorable response to neoadjuvant chemoimmunotherapy may improve outcomes in advanced stage III NSCLC.
Prognostic comparisons evaluate post-induction surgery against continued immunotherapy and chemotherapy in advanced lung cancer.
Matched retrospective cohort study evaluates therapeutic outcomes across surgical and systemic maintenance cohorts in stage III NSCLC.